On 2025-05-08, Monte Rosa Therapeutics, Inc. (GLUE) announced earnings per share of $0.57 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.24.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.31 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.24 | $0.57 |
| 2025-03-20 | 2024-12-31 | $-0.37 | $0.23 |
| 2024-11-07 | 2024-09-30 | $-0.45 | $-0.29 |
| 2024-08-08 | 2024-06-30 | $-0.50 | $-0.43 |
| 2024-05-09 | 2024-03-31 | $-0.56 | $-0.53 |
| 2024-03-14 | 2023-12-31 | $-0.57 | $-0.58 |
| 2023-11-09 | 2023-09-30 | $-0.75 | $-0.70 |
| 2023-08-10 | 2023-06-30 | $-0.72 | $-0.71 |
| 2023-05-11 | 2023-03-31 | $-0.70 | $-0.65 |
| 2023-03-16 | 2022-12-31 | $-0.64 | $-0.63 |
| 2022-11-10 | 2022-09-30 | $-0.61 | $-0.58 |
| 2022-08-11 | 2022-06-30 | $-0.54 | $-0.57 |
| 2022-05-11 | 2022-03-31 | $-0.53 | $-0.51 |
| 2021-11-10 | 2021-09-30 | $-0.46 | $-0.43 |
| 2021-08-12 | 2021-06-30 | $-0.41 | $-3.63 |